Clinical Trial Update: Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of MBX 1416 in Healthy Subjects [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study of MBX 1416 in healthy subjects to assess safety, tolerability, pharmacokinetics and pharmacodynamics in th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postbariatric Hypoglycemia

Drugs mentioned

• MBX 1416 (MBX-1416)

Snippet

Sponsor: MBX Biosciences | Conditions: Postbariatric Hypoglycemia | Phase 1 | Status: COMPLETED